Mednax, Inc. (MD): Price and Financial Metrics

MD POWR Grades

• Growth is the dimension where MD ranks best; there it ranks ahead of 99.78% of US stocks.
• The strongest trend for MD is in Growth, which has been heading up over the past 179 days.
• MD ranks lowest in Sentiment; there it ranks in the 35th percentile.

MD Stock Summary

• With a year-over-year growth in debt of -40.94%, Mednax Inc's debt growth rate surpasses only 9.99% of about US stocks.
• Over the past twelve months, MD has reported earnings growth of -133.91%, putting it ahead of merely 14.03% of US stocks in our set.
• Mednax Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 36.25%, greater than the shareholder yield of 95.42% of stocks in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Mednax Inc are PLOW, SP, CRS, VVPR, and WGO.
• MD's SEC filings can be seen here. And to visit Mednax Inc's official web site, go to www.mednax.com.

MD Valuation Summary

• MD's price/sales ratio is 1.5; this is 86.78% lower than that of the median Healthcare stock.
• MD's price/sales ratio has moved down 1.8 over the prior 243 months.
• MD's price/sales ratio has moved down 1.8 over the prior 243 months.

Below are key valuation metrics over time for MD.

MD Growth Metrics

Its 2 year revenue growth rate is now at -0.46%.
• Its 3 year cash and equivalents growth rate is now at -16.25%.
• Its 4 year net income to common stockholders growth rate is now at -479.58%.

MD's revenue has moved down $982,034,000 over the prior 70 months.

The table below shows MD's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	1,911.191	76.737	130.964
2021-09-30	1,829.291	20.635	19.152
2021-06-30	1,796.977	129.468	-52.687
2021-03-31	1,833.221	268.863	-760.134
2020-12-31	1,733.951	204.62	-796.488
2020-09-30	2,721.131	344.107	-722.861

MD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• MD has a Quality Grade of C, ranking ahead of 56.08% of graded US stocks.
• MD's asset turnover comes in at 0.609 -- ranking 45th of 81 Healthcare stocks.
• ENZ, TDOC, and LFMD are the stocks whose asset turnover ratios are most correlated with MD.

The table below shows MD's key quality metrics over time.